Literature DB >> 24481124

The prognostic value of T1 bladder cancer substaging: a single institution retrospective study.

V Soukup1, J Dušková, M Pešl, O Čapoun, Z Feherová, L Zámečník, T Hanuš, M Babjuk.   

Abstract

OBJECTIVE: To evaluate the prognostic value of the depth of lamina propria invasion in patients with T1 bladder cancer. SUBJECTS AND METHODS: 200 patients were treated between the years 2002 and 2009. Tumours with depth of invasion above the muscularis mucosae level were categorised as pT1a and those with depth of invasion up to or beyond the muscularis mucosae as pT1b.
RESULTS: Categorisation for pT1a and pT1b was performed in 176 of 200 patients (88%). In 10 patients a muscle-invasive tumour was found in re-transurethral resection samples. 131 (79%) of 166 analysed patients had pT1a tumour and 35 (21%) had pT1b tumour. During the follow-up, in 101 (61%) patients the tumour had recurred and in 27 (16.3%) the tumour had progressed. Of all the investigated parameters, T1 substaging (p < 0.0001), grade (p = 0.0003) and the number of bacillus Calmette-Guérin instillations (p = 0.0490) were significant in predicting progression. The only significant factor for disease-specific survival was T1 substaging in univariable (p = 0.0008) and multivariable (hazard ratio 4.407) analysis. T1 substaging (p = 0.0149) and tumour multiplicity (p = 0.0448) have a statistically significant prognostic value with respect to overall survival.
CONCLUSIONS: Deep invasion of the lamina propria is a significant adverse prognostic factor for tumour progression, disease-specific survival and overall survival. 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 24481124     DOI: 10.1159/000355358

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  6 in total

1.  The prognostic value of routine second transurethral resection in patients with newly diagnosed stage pT1 non-muscle-invasive bladder cancer: results from randomized 10-year extension trial.

Authors:  Askin Eroglu; Rahmi Gokhan Ekin; Gokhan Koc; Rauf Taner Divrik
Journal:  Int J Clin Oncol       Date:  2019-11-23       Impact factor: 3.402

2.  Stalk versus base invasion in pT1 papillary cancers of the bladder: improved substaging system predicting the risk of progression.

Authors:  Margaret Lawless; Roman Gulati; Maria Tretiakova
Journal:  Histopathology       Date:  2017-06-27       Impact factor: 5.087

3.  The evaluation of the risk factors for non-muscle invasive bladder cancer (NMIBC) recurrence after transurethral resection (TURBt) in Chinese population.

Authors:  Shenghua Liu; Junyao Hou; Hu Zhang; Yishuo Wu; Mengbo Hu; Limin Zhang; Jianfeng Xu; Rong Na; Haowen Jiang; Qiang Ding
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

4.  Risk Factors Predictive of Recurrence and Progression for Patients Who Suffered Initial Recurrence After Transurethral Resection of Stage pT1 Bladder Tumor in Chinese Population: A Retrospective Study.

Authors:  Zhonghua Shen; Linguo Xie; Tao Chen; Dawei Tian; Xiaoteng Liu; Hao Xu; Yu Zhang; Zhouliang Wu; Nan Sha; Chen Xing; Na Ding; Hailong Hu; Changli Wu
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

5.  Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder.

Authors:  Turgay Turan; Özgür Efiloğlu; Bilal Günaydin; Şeyma Özkanli; Emrah Nikerel; Gökhan Atiş; Turhan Çaşkurlu; Asif Yildirim
Journal:  Int Braz J Urol       Date:  2018 Mar-Apr       Impact factor: 1.541

6.  Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis.

Authors:  Mehdi Kardoust Parizi; Dmitry Enikeev; Petr V Glybochko; Veronika Seebacher; Florian Janisch; Harun Fajkovic; Piotr L Chłosta; Shahrokh F Shariat
Journal:  World J Urol       Date:  2019-09-06       Impact factor: 4.226

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.